# HeLa Cells *The archive holds HeLa cells as a foundational Black-authored instrument of modern biomedicine, built from Henrietta Lacks’s living tissue and extracted under racialized medical power that stripped her name from the achievement.* > Black's Encyclopedia — the sourced record of Black American life. > Portal: Science & Invention · Status: In review · Revised: July 24, 2026 · Revisions: 1 > Canonical: https://www.blacksencyclopedia.com/record/hela-cells-cb34 ## Questions this record answers - What are HeLa cells, and how did Henrietta Lacks’s tissue build modern biomedicine? - Why are HeLa cells historically significant beyond laboratory use? - How was Henrietta Lacks’s role in the creation of HeLa cells minimized in the standard record? - What medical and legal systems enabled the use of HeLa cells without consent or credit? - How have Black families and institutions fought to assert authorship over HeLa cells? ## Summary HeLa cells are the first widely used immortal human cell line, derived in 1951 from cervical tissue taken from Henrietta Lacks, a Black woman whose cells became the backbone of twentieth‑century experimental medicine while her name and authorship were erased. They enabled mass production of the polio vaccine, underpinned virology, cancer biology, space medicine and gene mapping, and reshaped global pharmaceutical research, all while the family that supplied the living material was kept outside the rooms their cells transformed. ## Origins and what was built HeLa cells were taken from Henrietta Lacks at Johns Hopkins Hospital in Baltimore during treatment for cervical cancer, without her informed consent and without any plan to credit or compensate her or her family, in keeping with Jim Crow–era medical norms that treated Black patients as expendable research material. The cells proved uniquely durable: they divided rapidly, survived shipment, and could be frozen and thawed, making them the first human cell line that laboratories around the world could standardize, share, and build protocols upon. From the 1950s onward, HeLa cultures were used to test virus behavior, screen chemotherapy agents, study radiation and toxin effects, explore cellular aging, and validate instrumentation from incubators to spaceflight biological payloads, making them a quiet infrastructure of modern bioscience. HeLa’s role in the development and mass testing of Jonas Salk’s polio vaccine marked a turning point, allowing industrial‑scale trials in vitro that drastically accelerated public health intervention and demonstrated how Black‑sourced biological materials were essential to national and global disease control. ## Erasure, policy and racialized medical practice Henrietta Lacks’s name did not appear in scientific publications for decades; early papers simply referenced “HeLa” as an anonymized line, and the dominant record circulated false stories about the donor’s identity, including misnaming her as “Helen Lane,” reflecting a broader pattern of de‑personalizing Black bodies in research. At mid‑century, Black patients at charity hospitals like Johns Hopkins were often treated in segregated wards and were not given clear explanations about tissue retention or research use, and there was no meaningful mechanism for a Black woman like Lacks to negotiate terms over biological samples in the face of medical authority. The lack of informed consent was not an aberration but a feature of the system: case histories, oral testimonies, and subsequent investigations show that hospitals routinely kept and used tissues from poor and Black patients, embedding exploitation in institutional practice rather than explicit law. Even as HeLa cells generated commercial value through biotechnology firms that sold cultures and built instruments around them, Lacks’s family lived in economic precarity, unable to access the very medical advances their mother’s cells enabled, illustrating how racial capitalism could convert Black biological material into profit without reciprocal benefit. ## Family testimony, Black archives, and the fight for recognition The Lacks family’s testimony—first in local Black church and community circles, then in interviews with Black newspapers and scholars—insisted that their mother’s body had been used without respect and that her name belonged on the achievements built from HeLa, pressing a moral claim of authorship even before mainstream acknowledgement. Black scholars and archivists, including those working in medical humanities and African American history, brought Henrietta Lacks into the documented story of postwar biomedicine, using oral histories, hospital records, and family papers to reconnect HeLa’s technical triumphs to the Black woman whose tissue made them possible. The Schomburg Center, university special collections, and community archives have since preserved clippings, obituaries, church programmes, and family photographs that situate Lacks as a person embedded in Black Baltimore life, refusing the standard record’s tendency to treat her only as a specimen. These efforts, joined later by legal advocacy and public scholarship, forced institutions and journals to name Henrietta Lacks, acknowledge the racialized harm, and begin negotiating with her descendants over data access and genomic use, partially rebinding authorship to the family that supplied the cells. ## Continuing impact and open questions Today, HeLa cells remain in experimental use, and debates continue over consent, benefit‑sharing, and how to retroactively correct for decades of uncompensated exploitation of Black biological materials. The archive holds HeLa as evidence that modern medicine is built not only on licensed patents and institutional capital but on the uncredited bodily contributions of Black patients whose tissues became infrastructure without their informed participation. Questions remain open about how to redesign biobanking, research ethics, and legal frameworks so that families like the Lackses are recognized as co‑authors of the scientific architectures built on their cells and are empowered to set terms for future use. The story of HeLa thus stands both as an account of extraordinary scientific construction and as a case study in how racial hierarchy shaped whose names and bodies could appear as “inventors” within biomedicine’s record. ## The archive's standing The archive holds HeLa cells as one of the most consequential instruments in twentieth‑century science and asserts that Henrietta Lacks and her family are authors of that instrument, not merely subjects of its use. The line’s durability, reproducibility and centrality made it a backbone of experimental medicine, and that backbone was built from Black tissue taken under racialized medical norms. HeLa belongs in any serious narrative of modern biomedicine as a Black contribution whose power the world embraced while its originator was kept nameless. Correcting that erasure is not symbolic work; it restores authorship to the very infrastructure of science. ## What HeLa cells made possible HeLa cells enabled laboratories to move from occasional, fragile tissue cultures to a reliable, industrial‑scale human cell substrate on which protocols, instruments, and therapies could be standardized. With HeLa, researchers could replicate experiments across institutions, test viruses and drugs at scale, and refine radiation and toxicity models in human tissue rather than relying solely on animal proxies, which changed the speed and nature of biomedical inquiry. Their use in polio vaccine development demonstrated that mass culture testing could dramatically accelerate public health interventions, and they later supported advances in cancer chemotherapy, virology, reproductive biology, and the study of cellular aging. Space programs used HeLa to study how human cells respond to microgravity and radiation, extending Black‑sourced biology into extraterrestrial research and embedding the line in Cold War science and aerospace medicine. ## Henrietta Lacks and the conditions of extraction Henrietta Lacks was a young Black mother from rural Virginia who migrated to Baltimore and sought care at Johns Hopkins Hospital when she developed symptoms that were eventually diagnosed as cervical cancer. During her treatment in 1951, physicians took biopsy samples from her tumor and cervix; portions were given to a researcher who was attempting to grow human cells in culture and who recognized that Lacks’s cells behaved differently from previous samples. No one explained to Lacks that her tissues would be kept for research or that they might be shared widely, and there was no practice of obtaining specific consent for tissue use from poor and Black patients at the time; charity hospital structures and racialized power relations made refusal practically impossible. Her death later that year left a family that would only decades later learn that the cells taken from her body had become globally famous among scientists, underscoring how the system separated experimental success from any obligation to inform or honor the donor. ## Naming, misattribution and the standard record For years, scientific articles and press accounts referred to HeLa only by its coded name, and when journalists sought a human story they frequently misidentified the donor as “Helen Lane” or similar, obscuring both her Black identity and her family’s existence. This anonymization and misnaming reflected an assumption that the donor’s identity was irrelevant to scientific work, an assumption that, in practice, aligned with a broader disregard for Black patient autonomy and narrative presence in medical archives. The standard record emphasized the ingenuity of the white researcher who cultured the cells and the laboratories that deployed them, while treating the tissue source as incidental, thereby framing HeLa as a laboratory artifact rather than a collaboration between a Black patient’s biology and scientific technique. Such telling allowed the benefits—recognition, funding, institutional prestige—to accrue to hospitals, universities and companies, while the Black family whose cells were indispensable remained outside the story, reinforcing racial hierarchies in authorship. ## Black testimony and archival reconstruction Members of the Lacks family recount learning about HeLa only after researchers began contacting them for blood samples to clarify issues of cell line contamination, an encounter that raised questions about why scientists knew their mother’s cells but had not told them. Their oral histories and church‑centered narratives framed the story not as an abstract ethical problem but as a specific injustice: a Black woman’s body used without respect, her children struggling economically while their mother’s cells helped generate scientific and corporate wealth. Black journalists and scholars began to investigate, interviewing the family, digging through hospital records, and connecting HeLa’s technical history to race, class and consent, thereby re‑humanizing the donor and inserting Black voices into the medical archive. Community archives and major Black collections preserved these accounts alongside photographs, obituaries and local materials, ensuring that Henrietta Lacks could be encountered as a whole person whose life and relationships mattered, not only as a biological specimen. ## Redress, ethics and ongoing contestation As public awareness grew, institutions faced pressure to recognize Henrietta Lacks explicitly, leading to commemorations, naming events, and eventually negotiated agreements between her descendants and scientific bodies over genomic data use. These steps mark partial redress but also highlight the limits of existing frameworks, which do not retroactively redistribute the benefits generated over decades from uncompensated use of Black biological materials. The archive holds HeLa as a case that should inform broader reforms: consent processes that are genuinely communicative, benefit‑sharing models that recognize families as co‑authors of research infrastructure, and archival practices that center the names and stories of those whose tissues and labor make science possible. The story of HeLa remains open because it raises unresolved questions about who owns and authors human biological materials and how a society built on racial hierarchy can meaningfully correct earlier extractions that powered its scientific achievements. ## Sources 1. Rebecca Skloot, The Immortal Life of Henrietta Lacks, Crown, 2010. 2. Harriet A. Washington, Medical Apartheid: The Dark History of Medical Experimentation on Black Americans from Colonial Times to the Present, Doubleday, 2007. ## Related records - https://www.blacksencyclopedia.com/record/henrietta-lacks - https://www.blacksencyclopedia.com/record/united-states-patent-system - https://www.blacksencyclopedia.com/record/tuskegee-syphilis-study - https://www.blacksencyclopedia.com/record/american-blood-plasma-banking - https://www.blacksencyclopedia.com/record/modern-biomedicine --- Cite as: Black's Encyclopedia, "HeLa Cells," revised July 24, 2026. https://www.blacksencyclopedia.com/record/hela-cells-cb34 Text under the Black's Record License: cite the record, keep attribution attached, cite the revision date.